Logo image of ALMEX.PA

MEXEDIA SPA (ALMEX.PA) Stock Fundamental Analysis

EPA:ALMEX - Euronext Paris - Matif - IT0005450819 - Common Stock - Currency: EUR

6.3  -0.6 (-8.7%)

Fundamental Rating

3

ALMEX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 27 industry peers in the Diversified Telecommunication Services industry. While ALMEX seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMEX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALMEX had negative earnings in the past year.
In the past year ALMEX had a positive cash flow from operations.
Of the past 5 years ALMEX 4 years were profitable.
In multiple years ALMEX reported negative operating cash flow during the last 5 years.
ALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

ALMEX has a Return On Assets of -12.70%. This is amonst the worse of the industry: ALMEX underperforms 85.19% of its industry peers.
ALMEX has a Return On Equity of -42.25%. This is amonst the worse of the industry: ALMEX underperforms 85.19% of its industry peers.
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROIC N/A
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMEX.PA Yearly ROA, ROE, ROICALMEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

ALMEX has a worse Gross Margin (10.15%) than 88.89% of its industry peers.
In the last couple of years the Gross Margin of ALMEX has grown nicely.
ALMEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
ALMEX.PA Yearly Profit, Operating, Gross MarginsALMEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

More info and screens

6

2. Health

2.1 Basic Checks

ALMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMEX has about the same amount of shares outstanding.
The number of shares outstanding for ALMEX remains at a similar level compared to 5 years ago.
ALMEX has a better debt/assets ratio than last year.
ALMEX.PA Yearly Shares OutstandingALMEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALMEX.PA Yearly Total Debt VS Total AssetsALMEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALMEX has an Altman-Z score of 0.11. This is a bad value and indicates that ALMEX is not financially healthy and even has some risk of bankruptcy.
ALMEX's Altman-Z score of 0.11 is on the low side compared to the rest of the industry. ALMEX is outperformed by 81.48% of its industry peers.
The Debt to FCF ratio of ALMEX is 3.19, which is a good value as it means it would take ALMEX, 3.19 years of fcf income to pay off all of its debts.
ALMEX has a better Debt to FCF ratio (3.19) than 85.19% of its industry peers.
ALMEX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ALMEX's Debt to Equity ratio of 0.10 is amongst the best of the industry. ALMEX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Altman-Z 0.11
ROIC/WACCN/A
WACC6.37%
ALMEX.PA Yearly LT Debt VS Equity VS FCFALMEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, ALMEX belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
ALMEX has a Quick Ratio of 1.12. This is a normal value and indicates that ALMEX is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.12, ALMEX belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
ALMEX.PA Yearly Current Assets VS Current LiabilitesALMEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALMEX have decreased strongly by -547.54% in the last year.
ALMEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -77.49%.
Measured over the past years, ALMEX shows a very negative growth in Revenue. The Revenue has been decreasing by -13.26% on average per year.
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMEX.PA Yearly Revenue VS EstimatesALMEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ALMEX.PA Yearly EPS VS EstimatesALMEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMEX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 2.41, the valuation of ALMEX can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALMEX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, ALMEX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.41
ALMEX.PA Price Earnings VS Forward Price EarningsALMEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALMEX is valued a bit more expensive than 70.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.89
EV/EBITDA N/A
ALMEX.PA Per share dataALMEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALMEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEXEDIA SPA

EPA:ALMEX (6/27/2025, 7:00:00 PM)

6.3

-0.6 (-8.7%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.91M
Analysts86
Price Target36.21 (474.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.41
P/S 0.49
P/FCF 22.89
P/OCF 4.35
P/B 0.76
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.51
EYN/A
EPS(NY)2.62
Fwd EY41.53%
FCF(TTM)0.28
FCFY4.37%
OCF(TTM)1.45
OCFY23%
SpS12.79
BVpS8.31
TBVpS-4.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.15%
FCFM 2.15%
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Debt/EBITDA N/A
Cap/Depr 520.54%
Cap/Sales 9.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 0.11
F-Score4
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)961.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%N/A
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-293.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.78%
FCF growth 3YN/A
FCF growth 5Y-13.29%
OCF growth 1Y16092.2%
OCF growth 3YN/A
OCF growth 5Y20.87%